Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.02 USD | 0.00% | -2.71% | -44.16% |
07/05 | Lucien Selce Urges Aurinia Pharmaceuticals Board to Take Action to Enhance Shareholder Value | CI |
02/05 | Transcript : Aurinia Pharmaceuticals Inc., Q1 2024 Earnings Call, May 02, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-44.16% | 72Cr | |
+5.66% | 11TCr | |
+11.23% | 11TCr | |
-2.18% | 2.19TCr | |
-12.15% | 2.23TCr | |
-5.52% | 1.86TCr | |
-36.52% | 1.81TCr | |
-10.09% | 1.7TCr | |
+3.33% | 1.37TCr | |
+36.58% | 1.24TCr |
- Stock Market
- Equities
- AUPH Stock
- News Aurinia Pharmaceuticals Inc.
- Oppenheimer Adjusts Price Target on Aurinia Pharmaceuticals to $13 From $15, Maintains Outperform Rating